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Background: In Parkinson disease (PD), patients often require burdensome assistance, delivered by
informal caregivers (eg, spouse).
Design: Prospective questionnaire and clinical-based investigation.
Objectives: To investigate both patient- and caregiver-derived factors contributing to caregiver burden (CB).
Methods: We assessed, in 59 patient-caregiver pairs, various motor, nonmotor, and cognitive symptoms
as well as quality of life by standardized tests and questionnaires. Repercussions on the caregiver were
evaluated by Zarit Burden Interview, Health-related Quality of Life (HrQoL), Generalized Anxiety Disorder
Assessment-7, Patient Health Questionnaire-9, and the Montreal Cognitive Assessment. Transcultural
comparison was ensured by validation of the tests in the 3 used languages.
Results: Sleep problems and autonomic dysfunction of the patient strongly impact CB (r ¼ 0.414 to
0.335, P < .01) and HrQoL of the caregiver (r ¼ 0.335 to 0.314, P < .05). Higher CB is less strongly
linked with patient’s motor impairment (P < .05). Large time investment, including nocturnal care in 41%
of the caregivers, strongly inﬂuences CB (P < .001). The mood, but not the cognitive status, of the
caregiver is directly linked to CB and HrQoL of the caregiver (P < .01).
Conclusion: In PD, the CB is primarily dependent on patients’ nonmotor symptoms. Patient care requires
considerable time investment and can trigger depression in the caregiver.
 2016 AMDA e The Society for Post-Acute and Long-Term Care Medicine. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Parkinson disease (PD) produces a variety of motor and nonmotor
symptoms.1 With disease progression, patients with PD require more
andmore assistance in their everyday life, often delivered by so-called
“informal caregivers” (eg, the spouse).2 Caregivers do not only enable
patients to remain in the community; their assistance also reduces the
risk of institutionalization3 and lessens the economic burden on soci-
ety.3e5 However, caregiving is burdensome and life-changing, brings
about the impoverishment of the caregiver’s social network, and con-
tributes to the disorganization of the family dynamics.4,6e9 Loss of in-
come and high medical costs of PD represent additional aggravating
factors.6 Several works have highlighted the negative impact on the
health of caregivers and their health-related quality of life (HrQoL).2,8,10n Think, Luxembourg. NJD is
by the Fonds National de
Prof. Dr. Diederich, Centre
L-1210 Luxembourg, G.D. of
n).
and Long-Term Care Medicine. ThSchrag et al8 reported that 40% of the caregivers experience a deteri-
oration of their health. The depression rate in caregivers is also higher
than in the general population.10 Alleviating the burden of the care-
givers is crucial, as elaboration of speciﬁc help programs,11 and even
optimization of the patient’smedical treatment,12 can be achieved only
with an in-depth knowledge on the contributory factors to this care-
giver burden (CB).13,14 Their individual impact has yet to be pondered
despite increasing interest in this research domain.2,7,8,10,13,15
This study addresses some of the crucial open issues. Which dis-
ease parameters inﬂuencemost notably the CB and caregiver’s HrQoL?
Are motor, or conversely, nonmotor symptoms more contributory?
What is the impact of caregiver’s inherent factors (mental and physical
health) on CB? Are there other major contributory factors?
Patients and Methods
Study Design
A cross-sectional study on patients from various outpatient con-
sultations was carried out from March 2014 to September 2014. Datais is an open access article under the CC BY-NC-ND license (http://creativecommons.
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ical and neuropsychological assessments.
Eligibility Criteria
The following inclusion criteria for patients were applied: (1)
diagnosis of PD according to UK Parkinson Disease Society Brain Bank
Criteria,16 stages I to IV on the Hoehn and Yahr scale17; (2) requirement
of at least minimal assistance, in, for example, holding a glass,
buttoning a shirt, performing administrative tasks; and (3) assistance
provided by an informal caregiver.
The deﬁnition of an informal caregiver, as previously proposed,2
was modiﬁed: in our study this person does not belong to any
professional care group, but actively assists the patients with PD.
The informal caregiver had to be sufﬁciently ﬂuent in French,
German, or English to be assessed. Both patient and caregiver had
to be capable of independently ﬁlling out the proposed
questionnaires.
The following exclusion criteria concerning the patient were
applied: (1) Any additional neurodegenerative disease, except non-
etype speciﬁc dementia, (2) chronic obstructive pulmonary disease,
(3) advanced heart failure with symptoms at rest deﬁned by the New
York Heart Association as class IV,18 (4) active cancer disease, (5)
history of stroke with considerable constraints in everyday life, or (6)
immobility due to other reasons than PD.
Recruitment Procedure and Participants
A total of 188 patients with PD were identiﬁed through different
outpatient clinics in Luxembourg. In a ﬁrst phone contact or face-to-
face interview, eligibility was determined (Figure 1). Thereafter 59
patient-caregiver dyads were included. Data were gathered through
door-to-door interviews and meetings in outpatient clinics. Patients
and caregivers were given detailed verbal and written information
and all ﬁnal participants signed an informed consent form. The
study was approved by the Luxembourgish National Research EthicsFig. 1. RecruitmenCommittee (reference 201403/08) and notiﬁed to the Lux-
embourgish National Data Protection Commission (reference
T009431).
Assessment Tools
The following tools were applied in the patient: Health-related
Quality of Life (EuroQoL EQ-5D-3L),19 Montreal Cognitive Assess-
ment (MoCA),20 the Scale for Outcomes of Parkinson’s Dis-
easeeAssessment Autonomic Dysfunction (SCOPA-AUT),21 Parkinson’s
Disease Sleep Scale (PDSS),22 Starkstein Apathy Scale (SAS),23 Move-
ment Disorder SocietyeUniﬁed Parkinson’s disease rating scale (MDS-
UPDRS) part III-IV,24 Hoehn and Yahr scale (H&Y),17 as well as a
sociodemographic questionnaire.
The following tools were applied in the caregiver: EuroQoL EQ-5D-
3L,19 Zarit Burden Interview (ZBI),25 General Anxiety Disorder-7
(GAD-7),26 Patient Health Questionnaire (PHQ-9),27 MoCA,20 socio-
demographic questionnaire. All questionnaires were administered in
French, German, or English.
The ZBI25 is a questionnaire composed of 22 items aimed at
appraising the burden experienced by caregivers. The respondent
indicates the frequency of various social, economic, and health as-
pects in relation with the caregiving task on a 5-point Likert scale
from 0 (never) to 4 (nearly always). A total score is formed by
adding the score of each individual item. A higher score reﬂects a
worse burden. The ZBI has been a reliable tool in different disease
settings28 or language translations.29,30 All versions used were
provided by Mapi Research Trust. The PHQ-9 (http://www.
phqscreeners.com/) essentially assesses the severity of depression
and consists of 9 items on a 4-point Likert scale from 0 (not at all) to
3 (nearly every day). A more severe depression comes along with a
higher total score. A cutoff score of 5 has been deﬁned.27 All used
language versions have been deemed reliable and valid,27,31,32
except some inconsistency was reported with the French
version.33 The GAD-7 (http://www.phqscreeners.com/) consists of 7
items that have to be answered on a Likert scale from 0 (not at all)t procedure.
Table 1
Description of Continuous Variables
Mean SD Min. Max.
Patient
EQ_VAS PATIENT 57.0 19.4 20.0 93.0
EQ-TARIFF PATIENT 0.5 0.3 0.2 1.0
PDSS 98.0 29.1 31.0 144.3
SCOPA-AUT 21.2 8.9 4.0 39.0
STARKSTEIN APATHY, n ¼ 53 14.7 6.3 4.0 30.0
MDS-UPDRS III, n ¼ 52 39.0 14.4 16.0 82.0
MDS-UPDRS AXIAL, n ¼ 52 10.6 5.0 3.0 25.0
MDS-UPDRS PERIPHERAL, n ¼ 52 26.0 10.0 7.0 54.0
MDS-UPDRS IV, n ¼ 52 8.0 3.9 0.0 23.0
Age of patient 69.4 9.8 43.0 85.0
Caregiver
ZBI 25.8 17.1 0.0 78.0
EQ_VAS_CAREGIVER 74.4 20.2 9.0 100.0
EQ-TARIFF CAREGIVER 0.7 0.3 0.0 1.0
GAD-7 7.4 5.6 0.0 21.0
PHQ-9 6.4 5.0 0.0 19.0
Age of caregiver 63.8 11.5 29.0 89.0
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severe anxiety.26 A cutoff of 5 points was been deﬁned for an elderly
population.32 The GAD-7 has been used in English, German, and
French studies.26,34,35 The EuroQol 5D-3L (EQ-5D-3L) is a 2-part
generic tool assessing HrQoL. In the ﬁrst part the respondent in-
dicates the severity of each item from “no problem” to “extreme
problems.” The score obtained is transformed into an index value
(EQ-Tariff),19 ranging from 1 (perfect health) to 0 (death). In the
second part, the respondent evaluates his or her actual health state
on a visual analogue scale (EQ-VAS) ranging from 100 (best imag-
inable health state) to 0 (worst imaginable health state) All trans-
lations have been issued by the EuroQol Group.19 The MoCA (http://
www.mocatest.org) evaluates different domains of cognition,
including executive function. As a screening test, it has a high
sensitivity for mild cognitive impairment (MCI).20 A cutoff score at
21 points differentiates accurately between PD-MCI and PD-De-
mentia.36 The French and German versions have been deemed valid
and reliable.20,37
The MDS-UPDRS is a general evaluation tool for PD.38 It has
excellent psychometric properties and translations have been issued
by the International Parkinson and Movement Disorder Society. In
this study, parts III and IV were used. Part III was subdivided into an
axial (items 3.1, 3.2, 3.3a, 3.9, 3.10, 3.11, 3.12, 3.13, 3.17e) and a pe-
ripheral (items 3.3b-e, 3.4a-b, 3.5a-b, 3.6a-b, 3.7a-b, 3.8a-b, 3.15a-b,
3.16 a-b, 3.17a-d) part. The H&Y ascertains the global severity of PD
on a scale of 1 to 5.17 Despite its psychometric deﬁciencies, the wide
distribution and simple employment still make it a valuable tool.39
The PDSS consists of 15 items covering different aspects of the sleep
of a patient with PD during the week before time ﬁlling out the
questionnaire.22 On a VAS, each item is rated from 0 (awful/never)
to 10 (excellent/always), either by the caregiver or patient. A higher
total score (range: 0e150) indicates a worse sleep experience. The
questionnaire was found to satisfy basic psychometric properties in
various cultures.40,41 All versions used were provided by Mapi
Research Trust. The SAS measures the presence and severity of
apathy in patients with PD. It consists of 14 items on a 4-level Likert
scale (0e3). A higher total score reﬂects a more pronounced
apathy.23 Validity and reliability have been deemed satisfying,42 but
so far there are no data for the French and German versions. All
language versions have been provided by the author of the scale.
The SCOPA-AUT (http://www.scopa-propark.eu/) is a questionnaire
assessing the severity of different nonmotor symptoms in patients
with PD. It consists of 23 items on a 4-point Likert scale from
0 (never) to 3 (often). The 2 sexual items were allowed to be
answered with “not applicable.” More advanced dysfunction trans-
lates into a higher total score.21 Psychometric requirements of the
English and Brazilian/Portuguese version are considered satis-
fying.21,43 The English version has been translated into French and
German by the authors.
Data Analysis
Descriptive statistics were carried out by computing extremes,
means, and SD values for continuous variables and frequencies as well
as proportions for categorical variables. The Shapiro-Wilk Test was
applied to assess normality of continuous variables. Correlations
among ZBI, HrQoL of the caregiver (EQ-Tariff & EQ-VAS), and contin-
uous variables of the caregiver and patients were computed, using
Spearman rank correlation coefﬁcients. We adopted the partition of
the correlation coefﬁcient proposed by Martínez-Martín et al.2 Thus,
jrj< 0.30 was rated as weak, moderate if 0.30 to 0.59 and strong if 0.60
or higher. The relationship between ZBI and HrQoL of the caregiver
and categorical variables of the patients and caregivers was deter-
mined using the Mann-Whitney U (2 categories) or Kruskall-Wallis
test (>2 categories). No adjustment for multiplicity was made, asthe previous analyses have been descriptive in nature. The factor
analysis using principal-component method and varimax rotation
served to regroup variables that showed a signiﬁcant relationship
with ZBI. Absolute values below 0.3 were automatically suppressed.
Separate calculations were performed with (1) signiﬁcant variables of
the caregiver and (2) signiﬁcant variables of the patient. Two separate
regression models addressed the components from the factor analysis
of the caregiver and the patient. Internal consistency for various
questionnaires was assessed bymeans of the Cronbach a. As therewas
only one English-speaking participant, no psychometric calculations
were performed for this case. Signiﬁcancewas deﬁned as a P value less
than .05 and all tests were 2-tailed. Cases with missing data were
excluded pairwise. Analyses were performed using SPSS Version 22.0
(IBM Corp, IBM SPSS Statistics for Windows, Armonk, NY) and
Microsoft Excel 2007 (Microsoft, Redmond, WA).
Results
Demographics and Time Investment
Table 1 and eTable 1 show the continuous and descriptive variables
for both, caregivers PD patients are older than caregivers (P< .05). They
experience a worse HrQoL (P < .001). Caregivers caring for male PD
patients have a lower EQ-Tariff than caregivers caring for female pa-
tients (P¼ .03).Noother signiﬁcanteffect related todemographic factors
is observed for ZBI andHrQoL of the caregivers. Higher time investment
for caregiving induces higher ZBI scores (P < .001) and lower HrQoL of
caregivers (EQ-TariffP< .001;EQ-VASP¼ .003). Inparticular, careduring
night is associated with a higher ZBI (P < .001) of the caregiver.
Moderate Impact of Motor Performances of the Patient on CB
Although the MDS-UPDRS part III total score only weakly cor-
relates with ZBI (r ¼ 0.290, P < .05), a more robust correlation is
seen when splitting the score into its peripheral and axial sub-
scales (r ¼ 0.346, P < .05). The ZBI score of the caregiver rises
sharply when PD progresses from H&Y 1 to 2 (15.2  9.0 resp.
30.3  17) (Table 2). The HrQoL of the caregiver is not inﬂuenced
by the H&Y staging.
Robust Impact of Nonmotor Symptoms of the Patient on CB
Among the nonmotor parameters, PDSS has the strongest
impact on the CB, whereas SCOPA-AUT and PDSS demonstrate
Table 2
Correlation of ZBI, Caregiver HrQoL, and Various Variables
ZCBI EQ-TARIFF
CAREGIVER
EQ_VAS_
CAREGIVER
Nonmotor symptoms, patient HrQoL, and age
EQ_VAS PATIENT L.337* .335* .428*
EQ-TARIFF PATIENT L.334* .119 .160
AGE OF PATIENT .144 .059 .018
PDSS L.414* .281y .314y
SCOPA-AUT .335* .211 L.335*
STARKSTEIN APATHY, n ¼ 53 .237 .256 .164
Motor symptoms
MDS-UPDRS III, n ¼ 52 .290y .109 .136
MDS-UPDRS PERIPHERAL, n ¼ 52 .346y .221 .258
MDS-UPDRS AXIAL, n ¼ 52 .106 .163 .100
MDS-UPDRS IV, n ¼ 52 .203 .174 .173
Variables of caregiver
ZBI 1.000 L.540* L.505*
EQ_VAS_CAREGIVER L.505* .786* 1.000
EQ-TARIFF CAREGIVER L.540* 1.000 .786*
GAD-7 .592* L.556* L.587*
PHQ-9 .598* L.542* L.591*
AGE OF CAREGIVER .118 .234 .236
Spearman rank correlation coefﬁcients *P < .01; yP < .05 (2-tailed).
Note: bold values are statistically signiﬁcant (P < .05).
D. Grün et al. / JAMDA 17 (2016) 626e632 629more moderate correlations with ZBI and caregiver HrQoL (all jrj
ranging between 0.281 and 0.414, all P < .05). Of note, reduced
cognitive performance of the patient (at the level of either MCI or
dementia) has no direct impact on CB or HrQoL of the caregiver
(Table 3).
Moderate Inﬂuence of the HrQoL of the Patient on CB
We observed a moderate relationship between EQ-VAS and EQ-
Tariff of the patient and ZBI, respectively, HrQoL of the caregiver (all
jrj between 0.334 and 0.428, all P < .01).
CB and Caregiver Mood
Caregivers with depression have lower HrQoL scores and higher
ZBI scores (jrj ¼ 0.542 and 0.598). Caregivers experiencing depression
(n ¼ 33) or anxiety (n ¼ 34) have higher ZBI scores (all P < .01) and
lower EQ-VAS and EQ-Tariff scores than caregivers without these
symptoms (all P < .001).
Factor Analysis and Regression Model
The factor analysis identiﬁes 2 separate components for the patient
(Table 3). The ﬁrst factor essentially concerns nonmotor symptoms
and comprehends various nonmotor scales (PDSS, SCOPA-AUT) as well
as HrQoL (EQ-VAS and EQ-TARIFF). It explains 39.2% of the variance.
The second factor evaluates the impact of the motor syndrome, as
reﬂected by the MDS-UPDRS III peripheral part and H&Y. The factor
analysis also identiﬁes 2 separate components for the caregiver. Here
the ﬁrst factor is composed of the quality of life parameters and theTable 3
Factor Analysis With Varimax Rotation
(1) Patient’s HrQoL and
Nonmotor Symptoms
(2) Motor
Symptoms
PDSS 0.837
SCOPA-AUT 0.817
EQ_VAS PATIENT 0.749
EQ-TARIFF PATIENT 0.615 0.505
MDS-UPDRS PERIPHERAL 0.721
H&Y 0.712mood status (EQ-VAS, EQ-TARIFF, GAD-7, PHQ-9). It explains 48.7% of
the variance. The second factor includes the care investment (total
time invested in care; night care) (Fig 2). In the regression model both
patient factors predict ZBI of the caregiver (F ¼ 7.3, P ¼ .002; variance
23%). However, factor 2 reﬂecting motor performances of the patient
is less inﬂuential than factor 1, reﬂecting the nonmotor symptoms
(b ¼ 0.254, P ¼ .048 vs b ¼ 0.406, P ¼ .002). Both caregiver factors
predict ZBI more robustly (F ¼ 41.9, P < .001), as they explain 60% of
the variance; here the impact of both factors is similar.
Internal Consistency
Internal consistency is high for most questionnaires in both lan-
guages lying between a ¼ 0.78 and 0.94. Only the SAS, both in its
French (a ¼ 0.754) or German version (a ¼ 0.691) displays a lower
internal consistency.
Discussion
In PD, CB has a notable patient and societal impact. Beyond the
evident impact of patient’s motor handicap on CB, the present study
reveals an even more substantial impact on CB by nonmotor symp-
toms. It also highlights the considerable time investment, including
nighttime, and pinpoints the strong interactionwith caregiver’s mood.
The ZBI score (25.8 17.1) is similar to the value reported in a pioneer
study by Martínez-Martín et al2 and even slightly higher than in 2
other cohorts investigated by the same research team.5,10 As preva-
lence of PD is higher in men than women,44 most caregivers in this
study are also female spouses2,5,6,8,10 and younger than the patients.
These female caregivers caring for male patients with PD subjectively
experience higher CB, thus conﬁrming some weak gender effect on
CB.2,5,8,10,45
Predominant Impact of Nonmotor Symptoms of the Patient
Nonmotor symptoms, and in particular commonly occurring sleep
problems,46 have a higher impact on CB and HrQoL of the caregiver
than motor symptoms. These ﬁndings may appear counterintuitive at
ﬁrst look, as PD is considered by many as primarily a movement dis-
order.1 Other studies have similarly underscored the importance of
nonmotor symptoms.5,8,10,13,47 Nonmotor symptoms, in particular
depression, also shape more strongly the quality of life of the PD pa-
tient than motor symptoms.48,49 In this context, it is only surprising
that the cognitive performances of the patient have no impact on CB or
HrQoL of the caregiver. Although being conﬁrmed in the non-
Parkinsonian population with cognitive impairment,50 this ﬁnding
stands in contrast with other studies in PD.5,10,13,14,47,50,51 It has even
been suggested that the patient’s cognitive functioning maymodulate
the psychosocial burden of the caregiver.50 We argue that cognitive
impairment at the MCI stage may not be noticed in repetitive and
routine everyday tasks and wider tolerance and acceptance of
cognitive impairment may be culturally bounded. Different mea-
surement methodsmight also hold in part for divergent results. In this(3) Caregiver’s HrQoL
and Mood Status
(4) Care
Expense
EQ_VAS_CAREGIVER 0.846
EQ-TARIFF CAREGIVER 0.824
GAD-7 0.845
PHQ-9 0.830
NIGHT CARE 0.914
TIME OF CARE PER DAY 0.347 0.767
Fig. 2. Night care and total amount of care time invested per day as reported by the caregivers.
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does not exert any signiﬁcant effect on CB, in contrast to previous
results.14,15 We presume that personal constructs, cultural differences,
and differential judgments on health again explain this tolerance by
the caregiver.
Concerning the impact of motor symptoms, peripheral motor
symptoms (eg, tremor of the arm), but not axial symptoms (eg,
postural instability), increase CB. Schrag et al8 have associated CB in
particular with falls of patients with PD. They asked patients directly
about falls, but did not formally assess postural stability. In another
study, applying an axial subscore similar to the present study; axial
symptoms were only evaluated regarding their inﬂuence on the pa-
tient with PD,53 but not on the caregiver. Although the impact of axial
symptoms on CB has thus been insufﬁciently explored in the past, our
study objectively dissects by an established tool the impact of pe-
ripheral and axial motor symptoms on caregiver strain.
Most studies have reported a negative impact of disease severity,
on either CB or HrQoL or on both,2,5,8e10 hence translating the rising
demand and complexity of the caregiver’s task. Interestingly, in our
study, disease severity only inﬂuences CB. Moreover, disease duration
has no negative impact on CB and HrQoL of the caregiver. This resil-
ience, although still partially contested,2,8,10 is encouraging, as it
suggests that caregivers may successfully adapt to the disease stage,
although the sustaining factors (eg, support by lay groups, medical
information, performances of the social security system) remain
elusive. Such an “adaptation,” already proposed by Martínez-Martín
et al,2 probably develops more easily with slow disease progression.54
Considerable Time Investment Impacting the CB
Frighteningly, in 41% of the caregivers, night sleep is disrupted so
as to provide adequate care to the patient. There is a robust link be-
tween night care and CB, as uncontested, poor sleep quality and life
quality are linked together.55 Furthermore, the total amount of care
time has a negative inﬂuence on CB2 and the HrQoL of the caregiver.
Mental Health of the Caregiver
The caregiver’s mental health is of foremost importance, as it takes
a front position in modulating CB.2,5,8,10 Concerns about the safety of
the patients directly increase the mental stress of the caregiver.7 We
indirectly conﬁrm such links as anxiety and depression, present in 42%
and 44%, respectively, of our caregivers, have a strong inﬂuence on CB.
Of note, depression, anxiety, and HrQoL are already linked,56 and both
emotional parameters aremore frequent in caregivers of patients with
PD than in the general population.10,56,57 In our study, both variables
also inﬂuence the HrQoL of the caregiver. Caregiver’s HrQoL itself is
ﬁnally an independent factor inﬂuencing CB. The caregivers assume
tasks previously carried out by the patient and retain not only theirown, but also organizational details of the daily schedule of the pa-
tient.6 As MCI may hinder this, we have hypothesized that MCI of the
caregiver may also inﬂuence CB. However, this is not (yet) the case. To
our knowledge, this is also the ﬁrst study exploring the potential
impact of the caregiver’s cognition on CB.
Limitations and Strengths
Our study displays several strengths allowing extending our
knowledge on the CB in PD. Exploring not only the impact of motor
symptoms but also the full range of nonmotor symptoms in PD depicts
amultilayered andmore realistic image of CB. The distinction between
the effect of PD-MCI and PD-Dementia sheds light on an ever-growing
aspect in PD research.58 We have been the ﬁrst to investigate the
impact of the caregiver’s cognition on CB. Finally, the almost exclusive
use of reliable measurements tools, validated in the 3 languages used
in this study and showing high internal consistency, substantially
contributes to the quality and robustness of the results and allows
transcultural comparisons. Such a cohort study also has unavoidable
limitations, starting with the relatively small sample size. Although all
disease-severity levels except H&Y stage 5 are represented, most of
the patients have H&Y stage 2. More frequent inclusion of patients at
higher H&Y stages (including stage 5) might have shown higher CB. It
is also possible that, with more advanced disease, the impact on CB by
motor and cognitive impairment prevails again over the impact of the
nonmotor symptoms. Due to both organizational and statistical con-
straints, it has not been possible to take into account the individual
medical history and personality characteristics of the caregivers.
Therefore, it cannot be ruled out that for some caregivers, PD might
not constitute the predominant burden in everyday life. Finally, eco-
nomic burden, lack of resources, frustrations from communication
problems and mismatched expectations, all potential further
contributive factors to the caregiver strain, have not been explored in
the present study.59
Conclusion
In PD, nonmotor symptoms, especially sleep quality, exert a
stronger inﬂuence on CB and HrQoL of caregivers than motor
symptoms; CB increases with PD progression and nocturnal care with
serious repercussion on CB is remarkably frequent. This time
dimension of provided care warrants further in-depth analysis in
future studies. Finally, mental health of the caregiver directly in-
teracts with CB, although MCI of the caregiver has not yet a negative
impact on CB. We recommend a more thorough assessment of the
various components of CB in the future, this within the framework of
a holistic approach to PD. Health professionals should be attentive to
the often substantial CB of caregivers and detailed knowledge on the
disease evolution should be provided to them. Social support groups
D. Grün et al. / JAMDA 17 (2016) 626e632 631may also contribute to preserve physical and mental health of care-
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